InnovAge Holding Corp.: stock overview

INNVNASDAQHealthcare · Services-Health Services

Price

$9.47

November 13, 2026Market cap $1.3B

DCF calculator

What Ploutos Investor adds for InnovAge

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from FY2020
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

In short

InnovAge had revenue of $1.0B over the last 12 months and net income of $9.0M, a net margin of 0.9%. Revenue grew by 9.2% a year on average over the last 5 years. At $9.47 the shares trade at a P/E of 143.6. It holds more cash than debt, by $102M. It pays no dividend.

From its SEC filings (latest fiscal year to June 30, 2026) and the price of November 13, 2026.

Its SEC filings
Market cap
$1.3B
136M shares
P/E
143.6
Revenue, 12 months
$1.0B
+9.2% a year over 5 years
Net margin
0.9%
FY2025: -3.6%, above 42% of its industry

Worth knowing

What a holder would want to hear from the company's SEC filings of the last three years. Each with its filing, without comment.

3 fiscal years in figures

Each fiscal year's figures as the company filed them, and the share price at its end.

FY2024–FY2026 fiscal years

+13.8% a year over 2 years

  • FY2026Jun 30, 202610-K
    Revenue$990M
  • FY2025Jun 30, 202510-K
    Revenue$854M
  • FY2024Jun 30, 202410-K
    Revenue$764M

Fiscal years in figures

INNV's revenue, profit, cash flow and dividend with each year-end price, from FY2020 to FY2023, 4 more fiscal years

Part of Ploutos Investor, €9.99 a month

See the plans

Sign in with a free account to see the last 5 fiscal years.

Key figures

The company's current figures in five groups. Each term is explained behind its ⓘ.

Valuation

Market cap 3-year median: $673M
$1.3B
Enterprise value 
$1.2B
P/E 
143.6
EV / EBIT 
82.2
EV / Revenue 
1.2
P/B 3-year median: 2.5
5.1
FCF yield 3-year median: 3.1%
5.9%
Earnings yield 3-year median: -3.2%
0.7%

Profitability

Gross margin 
23.6%
Operating margin 
1.4%
Net margin 3-year median: -2.8%
0.9%
ROIC 
3.8%
ROIC, 5-year average 
-4.9%
ROE 
3.7%

Growth

Revenue, yearly change 
+15.9%
EPS, yearly change 
–
FCF, yearly change 
+89.5%
Revenue, average a year 
+9.2%

The yearly change compares FY2026 with FY2025.

Balance sheet

Cash 
$163M
Total debt 
$84M
Of which operating leases 
$23M
Net cash 
$102M
Net debt / EBITDA 
-2.9x
Interest cover 
–
Current ratio 
1.16

Balance sheet of September 30, 2026.

Returns to shareholders

Dividend yield 
0.00%
Buybacks 
–
Total returned 
0.00%
Shares, yearly change 
+0.6%
Valuation against its own pastEach fiscal year's P/E, P/FCF and P/B beside today's, and the DCF calculator for the company.Valuation

Against its industry

Where its margins and returns stood in fiscal 2025 among the SEC filers of its industry (SIC code 80).

Gross margin

18.0%

Above 10% of the 25 companies in its industry, and 19% of all.

Operating margin

-3.5%

Above 38% of the 62 companies in its industry, and 28% of all.

Net margin

-3.6%

Above 42% of the 68 companies in its industry, and 26% of all.

ROE

-11.8%

Above 20% of the 58 companies in its industry, and 18% of all.

ROA

-5.8%

Above 25% of the 69 companies in its industry, and 19% of all.

Revenue growth

11.8%

Above 49% of the 68 companies in its industry, and 67% of all.

From the yearly figures every company files with the SEC, for those with revenue of at least $25 million. The industry is the first two digits of the SIC code.

The company at the SEC

How it is registered and when its fiscal year ends.

Name at the SEC
InnovAge Holding Corp.
CIK
1834376
Exchange
NASDAQ
Industry (SIC)
8000 · Services-Health Services
Fiscal year ends
June 30
Latest annual report
June 30, 2026
Reporting currency
USD
Shares
136M

Other companies: Healthcare

The largest companies of the same sector, each with its own page.

The Healthcare sectorAll companies

The full analysis

What do InnovAge's filings show?

These are InnovAge's figures. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

Questions about INNV

Didn't find what you were looking for?

Ask us
What is INNV's market cap?

InnovAge Holding Corp.'s market cap is $1.3B, at a price of $9.47 on November 13, 2026 and 136M shares.

What is INNV's P/E?

INNV's P/E is 143.6, on earnings per share of $0.06 over the last 12 months.

How much revenue does INNV have?

InnovAge had revenue of $1.0B over the last 12 months. Over the last 5 years it changed by +9.2% a year on average.

Does INNV pay a dividend?

No. InnovAge paid no regular dividend over the last 12 months.

Where do the figures come from?

From InnovAge Holding Corp.'s SEC filings (10-K and 10-Q) and the share price. They hold no analyst estimates and no score, and they are not a recommendation.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.